Free Trial

Biomea Fusion (BMEA) News Today

Biomea Fusion logo
$6.28 -0.14 (-2.18%)
(As of 11/20/2024 ET)
Biomea Fusion’s icovamenib shows efficacy in Type 2 diabetes trial
Biomea Fusion, Inc. stock logo
Biomea Fusion FY2024 EPS Estimate Raised by HC Wainwright
Biomea Fusion, Inc. (NASDAQ:BMEA - Free Report) - Equities researchers at HC Wainwright raised their FY2024 earnings per share estimates for Biomea Fusion in a report issued on Thursday, October 31st. HC Wainwright analyst J. Pantginis now anticipates that the company will post earnings of ($3.97
Truist Financial Remains a Buy on Biomea Fusion (BMEA)
Oppenheimer Reaffirms Their Buy Rating on Biomea Fusion (BMEA)
Biomea Fusion, Inc. stock logo
Biomea Fusion's (BMEA) "Buy" Rating Reaffirmed at HC Wainwright
HC Wainwright restated a "buy" rating and issued a $40.00 price objective on shares of Biomea Fusion in a research note on Thursday.
Barclays Keeps Their Hold Rating on Biomea Fusion (BMEA)
Biomea Fusion price target raised to $11 from $9 at Barclays
Biomea Fusion, Inc. stock logo
Barclays Increases Biomea Fusion (NASDAQ:BMEA) Price Target to $11.00
Barclays lifted their price target on shares of Biomea Fusion from $9.00 to $11.00 and gave the company an "equal weight" rating in a research note on Wednesday.
Biomea Fusion, Inc. stock logo
Biomea Fusion (NASDAQ:BMEA) Releases Quarterly Earnings Results, Beats Expectations By $0.03 EPS
Biomea Fusion (NASDAQ:BMEA - Get Free Report) announced its quarterly earnings results on Tuesday. The company reported ($0.91) earnings per share for the quarter, beating analysts' consensus estimates of ($0.94) by $0.03.
Biomea Fusion options imply 6.1% move in share price post-earnings
Biomea Fusion, Inc. stock logo
Biomea Fusion, Inc. (NASDAQ:BMEA) Receives Consensus Rating of "Buy" from Brokerages
Biomea Fusion, Inc. (NASDAQ:BMEA - Get Free Report) has earned an average recommendation of "Buy" from the twelve ratings firms that are presently covering the stock, MarketBeat reports. Two investment analysts have rated the stock with a hold recommendation, eight have issued a buy recommendation
Biomea Fusion, Inc. stock logo
Biomea Fusion's (BMEA) Buy Rating Reiterated at HC Wainwright
HC Wainwright reissued a "buy" rating and issued a $40.00 price objective on shares of Biomea Fusion in a research note on Tuesday.
Biomea Fusion announces approval of ‘icovamenib’ as INN for BMF-219
Biomea Fusion, Inc. stock logo
Biomea Fusion, Inc. (NASDAQ:BMEA) Shares Purchased by Griffin Asset Management Inc.
Griffin Asset Management Inc. raised its stake in shares of Biomea Fusion, Inc. (NASDAQ:BMEA - Free Report) by 147.0% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 96,070 shares of the company's stock after
Biomea Fusion, Inc. stock logo
Squarepoint Ops LLC Invests $237,000 in Biomea Fusion, Inc. (NASDAQ:BMEA)
Squarepoint Ops LLC bought a new stake in shares of Biomea Fusion, Inc. (NASDAQ:BMEA - Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 52,628 shares of the company's stock, va
Biomea Fusion, Inc. (BMEA)
Biomea Fusion, Inc. stock logo
Biomea Fusion (NASDAQ:BMEA) Raised to "Strong-Buy" at EF Hutton Acquisition Co. I
EF Hutton Acquisition Co. I raised Biomea Fusion to a "strong-buy" rating in a report on Wednesday.
Biomea Fusion, Inc. stock logo
Renaissance Technologies LLC Purchases Shares of 329,106 Biomea Fusion, Inc. (NASDAQ:BMEA)
Renaissance Technologies LLC acquired a new position in shares of Biomea Fusion, Inc. (NASDAQ:BMEA - Free Report) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 329,106 shares of the company's stock
Biomea Fusion, Inc. stock logo
Biomea Fusion, Inc. (NASDAQ:BMEA) Given Average Rating of "Moderate Buy" by Analysts
Biomea Fusion, Inc. (NASDAQ:BMEA - Get Free Report) has received a consensus recommendation of "Moderate Buy" from the eleven analysts that are currently covering the company, Marketbeat.com reports. Two investment analysts have rated the stock with a hold rating, eight have issued a buy rating an
Biomea Fusion, Inc. stock logo
Biomea Fusion (NASDAQ:BMEA) Stock Rating Upgraded by RODMAN&RENSHAW
RODMAN&RENSHAW raised shares of Biomea Fusion to a "strong-buy" rating in a report on Thursday.
Oppenheimer Sticks to Its Buy Rating for Biomea Fusion (BMEA)
Piper Sandler Remains a Buy on Biomea Fusion (BMEA)
Biomea Fusion, Inc. stock logo
Biomea Fusion Sees Unusually Large Options Volume (NASDAQ:BMEA)
Biomea Fusion, Inc. (NASDAQ:BMEA - Get Free Report) was the recipient of unusually large options trading activity on Friday. Traders bought 9,805 call options on the company. This represents an increase of 1,010% compared to the average volume of 883 call options.
Biomea Fusion, Inc. stock logo
Scotiabank Increases Biomea Fusion (NASDAQ:BMEA) Price Target to $41.00
Scotiabank boosted their target price on Biomea Fusion from $21.00 to $41.00 and gave the stock a "sector outperform" rating in a research report on Friday.
Biomea Fusion, Inc. stock logo
Biomea Fusion (NASDAQ:BMEA) Stock Rating Upgraded by Truist Financial
Truist Financial raised shares of Biomea Fusion from a "hold" rating to a "buy" rating and set a $54.00 price objective on the stock in a research note on Friday.
Get Biomea Fusion News Delivered to You Automatically

Sign up to receive the latest news and ratings for BMEA and its competitors with MarketBeat's FREE daily newsletter.

2025 AI Stock Picks: 2 Hidden Gems Under $10/Share (Ad)

The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.

👉[Click here to get your FREE report delivered instantly!]

BMEA Media Mentions By Week

BMEA Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BMEA
News Sentiment

-0.23

0.45

Average
Medical
News Sentiment

BMEA News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BMEA Articles
This Week

1

3

BMEA Articles
Average Week

Get Biomea Fusion News Delivered to You Automatically

Sign up to receive the latest news and ratings for BMEA and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:BMEA) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners